Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 22 of 50119 for:    will | Recruiting, Not yet recruiting, Available Studies

Study Proposal for Web Based Intervention to Promote the Safe Usage of Dating Applications in Young Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03685643
Recruitment Status : Recruiting
First Posted : September 26, 2018
Last Update Posted : September 28, 2018
Sponsor:
Information provided by (Responsible Party):
The University of Hong Kong

Brief Summary:
This study will evaluate the effectiveness of a program in promoting the safe usage of dating applications amongst young adults in Hong Kong. One group will receive the program regarding dating applications and the other group will receive a placebo program regarding health and exercise.

Condition or disease Intervention/treatment Phase
Sex, Unsafe Adolescent Behavior Behavior, Sex Behavioral: Intervention - Dating application topic Behavioral: Control - Health and exercise topic Not Applicable

Detailed Description:

Dating applications are a popular platform to meet new people; however, they have been associated with risks such as unsafe sexual behavior and privacy concerns in young adults.

The study design is an open-labeled cluster randomized controlled trial with an intervention and a placebo control arm. The intervention group will receive a web-based intervention developed through focus group discussions, crowdsourcing contest, and a Peer-Vetted Creative Production (PVCP) workshop comprising of four short videos, a risk assessment tool, and a scenario game. The control group will receive a web-based resource with similar multimedia elements on health and exercise.

Based on the Information, Motivation, and Behavioral Skills (IMB) Model, the primary outcome of this study is self-efficacy in using dating applications measured by the General Self Efficacy Scale. Secondary outcomes include change in attitudes regarding risk perception measured by the Risk Propensity Scale and depression symptoms.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 280 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Study Protocol for a Peer-led Web-based Intervention to Promote Safe Usage of Dating Applications Amongst Young Adults: A Cluster Randomized Controlled Trial
Actual Study Start Date : May 7, 2018
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : August 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention - Dating application topic
The intervention will consist of four short videos with points of discussion, a scenario game, and a risk assessment tool regarding dating application usage.
Behavioral: Intervention - Dating application topic
The intervention will consist of multimedia content to promote the safe usage of dating applications and raise awareness of the risks associated with dating application usage. The intervention will be delivered one-time in a classroom setting.

Placebo Comparator: Control - Health and exercise topic
The control will consist of four short videos with discussion points and an interaction game regarding exercise and healthy living tips.
Behavioral: Control - Health and exercise topic
The placebo control will consist of multimedia content regarding exercise and healthy living. It will be delivered once-time in a classroom setting.




Primary Outcome Measures :
  1. Self efficacy: This will be measured by the General Self Efficacy Scale [ Time Frame: 1 month ]
    The primary outcome will be the self-efficacy on the safe usage of dating. applications among young adults in Hong Kong. This will be measured by the General Self Efficacy Scale. The General Self Efficacy Scale is a 10-item scale (with 4 level Likert scale ranging from "not true at all" to "exactly true") measuring one's self-belief in completing certain tasks or overcoming difficulties. The total score is calculated by finding the sum of all items with the total score ranging between 10 and 40, with a higher score indicating a higher level of self efficacy.


Secondary Outcome Measures :
  1. Risk taking tendencies will be measured by the The Risk Propensity Scale. [ Time Frame: 1 month ]
    Participants' risk taking tendencies will be measured by the The Risk Propensity Scale. It is a 9-item scale measuring general risk-taking tendencies. Each item is rated on a 9 level Likert scale (ranging from "totally disagree" to "totally agree") with the final score ranging from 1-9. A higher score indicates higher risk-taking tendencies.

  2. Depression symptoms will be measured by the Patient Health Questionnaire-2 (PHQ-2). [ Time Frame: 1 month ]
    Participants' risk of depression will be measured by the Patient Health Questionnaire-2 (PHQ-2). This is a 2 item scale (with a 4 level Likert scale ranging from "Not at all" to "Nearly everyday") and the score ranges from 0-6, with a higher score indicating higher risk of depression.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   17 Years to 27 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 17-27 years old
  • Able to read and understand Chinese

Exclusion Criteria:

  • Have a physical impediment (e.g. blindness) to prevent them from accessing the content

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03685643


Contacts
Layout table for location contacts
Contact: Tsz Hei Stephanie Lau, MPH (852) 2518 5681 slau7@hku.hk
Contact: Kitty Choi, BA (852) 2518 5656 kccwy@hku.hk

Locations
Layout table for location information
Hong Kong
Caritas Institute of Community Education Not yet recruiting
Hong Kong, Hong Kong
Contact: Thomas Wong, PhD    (852)2239-6377    twong@cice.edu.hk   
Vocational Training Council (VTC) Recruiting
Hong Kong, Hong Kong
Contact: William Mak, MSc    (852)3127-5825    williammak@vtc.edu.hk   
Sponsors and Collaborators
The University of Hong Kong
Investigators
Layout table for investigator information
Principal Investigator: William Wong, MPH MD MFPH The University of Hong Kong

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: The University of Hong Kong
ClinicalTrials.gov Identifier: NCT03685643     History of Changes
Other Study ID Numbers: 09160275
HKUCTR-2512 ( Registry Identifier: HKU Clinical Trials Registry )
First Posted: September 26, 2018    Key Record Dates
Last Update Posted: September 28, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: The data will include baseline demographics, dating application usage and behavior, and the primary and secondary outcomes.
Supporting Materials: Study Protocol
Informed Consent Form (ICF)
Time Frame: Data will be available 6 months after study completion.
Access Criteria: Data access requests will be reviewed by an external review panel.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by The University of Hong Kong:
Peer-led, dating applications, young adults, sexual behavior